|
Jul 17
|
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
|
|
Jul 17
|
OKYO reports top-line data from neuropathic corneal pain therapy trial
|
|
May 19
|
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
|
|
Apr 30
|
OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
|
|
Mar 10
|
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
|